| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 11/05/2020 | 8:00AM | GlobeNewswire Inc. | Innate Pharma Launches HopeConnectLearn: A New Online Resource for Hairy Cell Leukemia Patients | EU:IPH | Innate Pharma |
| 10/23/2020 | 8:00AM | Dow Jones News | Innate Pharma Gets $50 Million Milestone Payment From AstraZeneca | EU:IPH | Innate Pharma |
| 10/23/2020 | 1:00AM | GlobeNewswire Inc. | First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers $50M Payment From AstraZeneca | EU:IPH | Innate Pharma |
| 10/23/2020 | 1:00AM | GlobeNewswire Inc. | First patient dosed in monalizumab Phase 3 clinical trial triggers $50M payment from AstraZeneca | EU:IPH | Innate Pharma |
| 10/23/2020 | 1:00AM | GlobeNewswire Inc. | L'inclusion du premier patient dans l'essai clinique de Phase 3 avec monalizumab déclenche un paiement de 50M$ d'AstraZeneca... | EU:IPH | Innate Pharma |
| 10/13/2020 | 1:00AM | GlobeNewswire Inc. | Number of Shares and Voting Rights of Innate Pharma as of October 1, 2020 | EU:IPH | Innate Pharma |
| 10/13/2020 | 1:00AM | GlobeNewswire Inc. | NOUVEAU NOMBRE D’ACTIONS ET DE DROITS DE VOTE D’INNATE PHARMA AU 1ER OCTOBRE 2020 | EU:IPH | Innate Pharma |
| 10/13/2020 | 1:00AM | GlobeNewswire Inc. | Number of Shares and Voting Rights of Innate Pharma as of October 1, 2020 | EU:IPH | Innate Pharma |
| 09/08/2020 | 1:00AM | GlobeNewswire Inc. | Innate Pharma reports first half 2020 financial results and business update | EU:IPH | Innate Pharma |
| 09/08/2020 | 1:00AM | GlobeNewswire Inc. | Innate Pharma Reports First Half 2020 Financial Results and Business Update | EU:IPH | Innate Pharma |
| 09/08/2020 | 1:00AM | GlobeNewswire Inc. | Innate Pharma présente ses résultats financiers et l'avancée de son portefeuille au premier semestre 2020 | EU:IPH | Innate Pharma |
| 09/04/2020 | 1:00AM | GlobeNewswire Inc. | Upcoming Investor Conferences | EU:IPH | Innate Pharma |
| 09/04/2020 | 1:00AM | GlobeNewswire Inc. | Upcoming investor conferences | EU:IPH | Innate Pharma |
| 09/04/2020 | 1:00AM | GlobeNewswire Inc. | Prochains rendez-vous investisseurs | EU:IPH | Innate Pharma |
| 08/12/2020 | 1:00AM | GlobeNewswire Inc. | Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er août 2020 | EU:IPH | Innate Pharma |
| 08/12/2020 | 1:00AM | GlobeNewswire Inc. | Number of shares and voting rights of Innate Pharma as at August 1, 2020 | EU:IPH | Innate Pharma |
| 08/11/2020 | 1:00AM | GlobeNewswire Inc. | Innate Pharma obtient un financement public de 6,8M€ pour ses activités de recherche et développement dans la COVID-19 | EU:IPH | Innate Pharma |
| 08/11/2020 | 1:00AM | GlobeNewswire Inc. | Innate Pharma Obtains €6.8M in Public Funding for Its COVID-19 Research And Development Activities | EU:IPH | Innate Pharma |
| 08/11/2020 | 1:00AM | GlobeNewswire Inc. | Innate Pharma obtains €6.8M in public funding for its COVID-19 research and development activities | EU:IPH | Innate Pharma |
| 07/29/2020 | 5:30AM | GlobeNewswire Inc. | Innate Pharma Announces Publication of EXPLORE COVID-19 Translational Study Findings in Nature | EU:IPH | Innate Pharma |
| 07/29/2020 | 5:30AM | GlobeNewswire Inc. | INNATE PHARMA ANNONCE LA PUBLICATION DANS NATURE DES RESULTATS DE L’ETUDE TRANSLATIONNELLE EXPLORE COVID-19 | EU:IPH | Innate Pharma |
| 07/29/2020 | 5:30AM | GlobeNewswire Inc. | INNATE PHARMA ANNOUNCES PUBLICATION OF EXPLORE COVID-19 TRANSLATIONAL STUDY FINDINGS IN NATURE | EU:IPH | Innate Pharma |
| 07/16/2020 | 1:00AM | GlobeNewswire Inc. | Innate Pharma Announces the Appointment of Joyson Karakunnel, MD, MSC, FACP as Chief Medical Officer | EU:IPH | Innate Pharma |
| 07/16/2020 | 1:00AM | GlobeNewswire Inc. | Innate Pharma announces the appointment of Joyson Karakunnel, MD, MSC, FACP as Chief Medical Officer | EU:IPH | Innate Pharma |
| 07/16/2020 | 1:00AM | GlobeNewswire Inc. | Innate Pharma annonce la nomination de Joyson Karakunnel, MD, MSC, FACP, au poste de Directeur Médical | EU:IPH | Innate Pharma |
| 06/24/2020 | 1:00AM | GlobeNewswire Inc. | L'agence américaine du médicament lève la suspension partielle de l'essai TELLOMAK évaluant lacutamab chez les patients p... | EU:IPH | Innate Pharma |
| 06/24/2020 | 1:00AM | GlobeNewswire Inc. | U.S. Food and Drug Administration Lifts Partial Clinical Hold on Lacutamab TELLOMAK Trial in Advanced T-Cell Lymphomas | EU:IPH | Innate Pharma |
| 06/24/2020 | 1:00AM | GlobeNewswire Inc. | U.S. Food and Drug Administration lifts partial clinical hold on lacutamab TELLOMAK trial in advanced T-cell lymphomas | EU:IPH | Innate Pharma |
| 05/20/2020 | 1:00AM | GlobeNewswire Inc. | Outcome Of Annual General Meeting Of May 19, 2020 | EU:IPH | Innate Pharma |